S&P 500
7,246.40
+0.28%
Dow Jones
49,503.60
+0.02%
Nasdaq 100
27,836.60
+0.55%
Russell 2000
2,812.31
+0.27%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,862.50
+1.02%

Health and Healthcare

Analyst Sees 55% Upside in Small Biotech

Photo of Jon C. Ogg
By Jon C. Ogg Updated Published
Follow 24/7 Wall St. on Google
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Thinkstock
Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) was covered this morning in our analyst upgrades and downgrades daily summary, but call is worth a closer look. Deutsche Bank initiated the small biotech with a BUy rating. What was more impressive is the $7.00 price target objective because that indicated about 55% upside from the $4.52 closing price on Tuesday.

What makes this call so interesting is that the company just announced earlier this week that its management will present in a fireside chat at the 2012 Deutsche Bank Access BioFEST Conference on December 3, 2012 in Boston. With a focus on hepatitis B and C it seems as though investors are hoping that the company’s pipeline in Phase II studies will have significant upside since Idenix has estimated that more than 170 million people worldwide are chronically infected with HCV.

Shares are up a sharp 13% at $5.13 on the news and the volume is already closing in on 1 million shares after only about an hour of trading. Idenix has a $685 million market cap and shares have a 52-week range of $3.35 to $15.25. Another observation is that the consensus analyst target is already about $7.20 here with a range of $4.00 to $15.00 for the stock.

JON C. OGG

Photo of Jon C. Ogg
About the Author Jon C. Ogg →

Jon Ogg has been a financial news analyst since 1997. Mr. Ogg set up one of the first audio squawk box services for traders called TTN, which he sold in 2003. He has previously worked as a licensed broker to some of the top U.S. and E.U. financial institutions, managed capital, and has raised private capital at the seed and venture stage. He has lived in Copenhagen, Denmark, as well as New York and Chicago, and he now lives in Houston, Texas. Jon received a Bachelor of Business Administration in finance at University of Houston in 1992. a673b.bigscoots-temp.com.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving
David Beren |

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving
A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up
Drew Wood |

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

Continue Reading

Jon C. Ogg |

8 Stocks That Analysts Think Will Double

Now that October has arrived, 24/7 Wall St. wanted to review some of the most aggressive recent analyst calls.
Jon C. Ogg |

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

ThinkstockIdenix Pharmaceuticals Inc. (NASDAQ: IDIX) was the biggest gainer of all listed stocks on Friday with a rally of 40%.…
Jon C. Ogg |

24/7 Wall St. Top 10 Analyst Calls of the Week (AIG, COG, CPST, CBOE, CTXS, JDSU, MMYT, RSH, S, WYNN)

Jon OggEach morning we cover about 15 to 20 analyst upgrades and downgrades which we think will have an impact…
7 Analyst Stocks Under $10 With Massive Upside Potential
Jon C. Ogg |

7 Analyst Stocks Under $10 With Massive Upside Potential

24/7 Wall St. is always on the hunt for undiscovered opportunities and hidden value in the financial markets. After all,…
Jon C. Ogg |

8 Fresh Analyst Stock Picks With 50% to 100% Upside

Did the stock market find a formal bottom last week? That is what investors must be wondering now.
Jon C. Ogg |

9 Oil and Gas Stocks Analysts Want You to Buy Now

24/7 Wall St. has reviewed nine different analyst calls in the energy sector with solid upside targets. Some obviously have…
Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More
Jon C. Ogg |

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

The top analyst upgrades, downgrades and other research calls from Friday include AK Steel, Altice USA, Biogen, Caterpillar, Gilead Sciences…
Why Deutsche Bank Sees Texas Roadhouse Benefiting Big From the Reopening Trade
Chris Lange |

Why Deutsche Bank Sees Texas Roadhouse Benefiting Big From the Reopening Trade

One analyst thinks Texas Roadhouse stock is poised to benefit from the reopening trade. How much upside potential is there?
Jon C. Ogg |

24/7 Wall St. Top Analyst Calls of the Week (CARB, GLW, DG, INTC, LOGI, LULU, MAKO, MCD, MCP, NFLX, NBG, P, RENN, YHOO, YNDX, YOKU, LVS, WYNN, BAC, WFC)

Jon OggEach morning we review our top upgrades, downgrades and initiations from Wall St. research notes. We then look back…

Top Gaining Stocks

Cboe Global Markets
CBOE • Vol: 1,568,143
New Pluto Global
PSKY • Vol: 12,285,993
Seagate Technology
STX • Vol: 7,378,346
Oracle
ORCL • Vol: 26,317,675
Datadog
DDOG • Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ • Vol: 4,367,433
Clorox
CLX • Vol: 13,260,523
Stryker
SYK • Vol: 4,519,455
Mohawk Industries
MHK • Vol: 1,859,865
Amgen
AMGN • Vol: 3,818,618